Indaptus Therapeutics Inc. (INDP) stock Advances Further After Market
Indaptus Therapeutics Inc. (INDP) stock gained a further 17.50% in the after-hours on January 03. The stock seems to have advanced further after the announcement of Boyan Litchev, M.D. as CMO of the company. During the regular session, the stock added 8.25% at its close of $6.17 with 1.28 million shares exchanging. Following the announcement, …
Indaptus Therapeutics Inc. (INDP) stock Advances Further After Market Read More »